logo

For the Inventor, By the Inventor

Basel, Switzerland

Aleksandar Stojanovic

This inventor holds 24 USPTO granted patents and 4 published patent applications and 15 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Novartis Ag, Speedel Experimenta Ag, Novartis Pharma Ag. Active years: 2009-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aleksandar Stojanovic. Retrieved from https://idiyas.com/inventor/aleksandar-stojanovic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 4.2

 

Average Co-Inventor Count = 7.1

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Allschwil, CH (2009 - 2012)
  • Basel, CH (2010 - 2017)

Company Filing History:

goldMedal20 out of 3,977 
 
Novartis Ag
 patents
silverMedal3 out of 5 
 
Speedel Experimenta Ag
 patents
bronzeMedal1 out of 36 
 
Novartis Pharma Ag
 patents

Years Active: 2009-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Imidazo Derivatives
Aldosterone Inhibitors
Spiro-Compounds
Renin Inhibitors
Organic Compounds
Quinazolin Derivatives
Piperidine Derivatives
Amino Alcohols
Hydroxy Nonamide Derivatives
Condensed Imidazole
Bis-Heterocyclic Compounds
24 patents (USPTO):Explore Patents
1. 9840498 - Substituted quinazolin-4-one derivatives (2017-12-12),
2. 8324235 - Heterocyclic spiro-compounds (2012-12-04),
3. 8263615 - Bis-heterocyclic imidazolyl compounds (2012-09-11),
4. 8138179 - Spiro-imidazo compounds (2012-03-20),
5. 8138176 - Imidazo compounds (2012-03-20),
6. 8076327 - Condensed imidazole derivatives as aldosterone synthase inhibitors (2011-12-13),
7. 8071774 - Heterocyclic spiro-compounds as aldosterone synthase inhibitors (2011-12-06),
8. 8071773 - Heterocyclic spiro-compounds as aldosterone synthase inhibitors (2011-12-06),
9. 8071651 - 5-amino-4-hydroxy-7-(imidazo [1,2-A] pyridin-6-ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension (2011-12-06),
10. 8058307 - Alcanoic acid amides substituted by saturated O-heterocycles (2011-11-15),
11. 8008334 - Bis-heterocyclic imidazolyl compounds (2011-08-30),
12. 7879847 - Imidazo compounds (2011-02-01),
13. 7868036 - Organic compounds (2011-01-11),
14. 7851634 - 5-amino 4-hydroxy-7-(1H-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension (2010-12-14),
15. 7842688 - Organic compounds (2010-11-30),

Title: Inventor Aleksandar Stojanovic: Pioneering Innovations in Basel

Introduction: Aleksandar Stojanovic is a renowned inventor based in Basel, Switzerland, known for his groundbreaking contributions to various fields of technology and science.

Latest Patents: Stojanovic's recent patents include advancements in renewable energy systems, artificial intelligence algorithms, and medical devices, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the innovation industry, Stojanovic has led numerous successful projects from concept to commercialization, earning him a reputation as a visionary inventor.

Collaborations: Throughout his career, Stojanovic has collaborated with leading research institutions, universities, and multinational companies to push the boundaries of technological advancements and bring cutting-edge solutions to the market.

Conclusion: Inventor Aleksandar Stojanovic's relentless pursuit of innovation and his passion for creating transformative technologies continue to inspire the next generation of inventors and shape the future of industries worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…